AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2014

Jun 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2014-05-30

Reporting Person: Tessier-Lavigne Marc (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-30	Stock Option (right to buy)	$35.16	A	14000	Acquired	2024-05-29	Common Stock (14000)	Direct

Footnotes

F1: This option was granted on May 30, 2014. The shares underlying this option vest as to 100% of the underlying shares on May 30, 2015.